Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Harold E. Bays
Based on 25 articles published since 2007
||||
Expertise Level
The expertise of Harold E. Bays ranks in the
  • Top 0.061%
  • ... of 29,430 published authors worldwide on Hypercholesterolemia
  • ... from 2007 through 2018
  • ... based on contributions to 25 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Bays, Harold E   ·   Bays, H E   ·   Bays, H   ·   Bays, Harold
Work Locations
Details
Most likely:    Miscellaneous institutions in Louisville      
2017
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA. · Merck & Co, Inc, Kenilworth, NJ, USA. · MSD Ltd, Hoddeson, UK. Electronic address: · Pubmed 28647412
2016
  • Metabolic & Atherosclerosis Research Center, Cincinnati, OH. · Louisville Metabolic & Atherosclerotic Research Center, Louisville, KY. · Jacksonville Center for Clinical Research, Jacksonville, FL. · Gemphire Therapeutics Inc., Northville, MI. · Gemphire Therapeutics Inc., Northville, MI. Electronic address: · Pubmed 27678439
  • Baylor College of Medicine, Houston, Texas. Electronic address: · Louisville Metabolic and Atherosclerosis Research Center (L-MARC), Louisville, Kentucky. · Sanofi, Bridgewater, New Jersey. · Regeneron, Tarrytown, New York. · Sanofi, Chilly-Mazarin, France. · Regeneron, Basking Ridge, New Jersey. · University of Iowa, Iowa City, Iowa. · Pubmed 27729106
2015
  • Section of Cardiovascular Research, Division of Atherosclerosis, Department of Medicine, Baylor College of Medicine, Houston, Texas; Center for Cardiovascular Research, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. Electronic address: · Orange County Research Center, Tustin, California. · Clinical Sciences, Global Innovative Pharma Business, Pfizer Inc., Groton, Connecticut. · Statistics, Global Innovative Pharma Business, Pfizer Inc., Groton, Connecticut. · Clinical Pharmacology, Global Innovative Pharma Business, Pfizer Inc., New York, New York. · Clinical Pharmacology, Global Innovative Pharma Business, Pfizer Inc., Groton, Connecticut. · Clinical Sciences, Global Innovative Pharma Business, Pfizer Inc., New York, New York. · Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky. · Pubmed 25784512
  • Louisville Metabolic and Atherosclerosis Research Center, 3288 Illinois Avenue, Louisville, KY, 40213, USA. · Pubmed 25431239
2014
  • Jacksonville Center for Clinical Research, Jacksonville, Florida. Electronic address: · Center for Clinical and Basic Research, Ballerup, Denmark. · Bethesda Health Research Center, Bethesda, Maryland. · Orange County Research Center, Tustin, California. · Amgen Inc., Thousand Oaks, California. · L-MARC Research Center, Louisville, Kentucky. · Pubmed 24691094
2013
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky. Electronic address: · Pubmed 24063830
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA. · Pubmed 22948945
2011
  • Louisville Metabolic and Atherosclerosis Research Center, Inc., Louisville, Kentucky 40213, USA. · Pubmed 21856592
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky, USA. · Pubmed 21596364
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY 40213, USA. · Pubmed 20837371
2010
  • Louisville Metabolic and Atherosclerosis Research Center, 3288 Illinois Ave, Louisville, KY 40213, USA. · Pubmed 20118387
2008
  • Louisville Metabolic and Atherosclerosis Research Center, 3288 Illinois Avenue, Louisville, KY 40213, USA. · Pubmed 18402536
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY 40213, USA. · Pubmed 18782465
2014
  • Comprehensive Health Insights Inc., a Humana Company, 325 W. Main St., WFP6W, 40202, Louisville, KY, USA, · Pubmed 25091271
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 25 total) written by Harold E. Bays about Hypercholesterolemia:

  • Real-world data to assess changes in low-density lipoprotein cholesterol and predicted cardiovascular risk after ezetimibe discontinuation post reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial. 2017
  • Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients. 2016
  • Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials. 2016
  • Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia. 2015
  • Fixed-dose combination ezetimibe+atorvastatin lowers LDL-C equivalent to co-administered components in randomized trials: use of a dose-response model. 2015
  • Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 mg): design and rationale of the ODYSSEY OPTIONS Studies. 2014
  • Anti-PCSK9 monotherapy for hypercholesterolemia: the MENDEL-2 randomized, controlled phase III clinical trial of evolocumab. 2014
  • Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe. 2014
  • Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. 2013
  • Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercholesterolemia. 2013
Show List of Full Article Records
Google Searches

Learn more about Harold E. Bays using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Louisville
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Louisville
2017
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA. · Merck & Co, Inc, Kenilworth, NJ, USA. · MSD Ltd, Hoddeson, UK. Electronic address: · Pubmed 28647412
2016
  • Metabolic & Atherosclerosis Research Center, Cincinnati, OH. · Louisville Metabolic & Atherosclerotic Research Center, Louisville, KY. · Jacksonville Center for Clinical Research, Jacksonville, FL. · Gemphire Therapeutics Inc., Northville, MI. · Gemphire Therapeutics Inc., Northville, MI. Electronic address: · Pubmed 27678439
  • Baylor College of Medicine, Houston, Texas. Electronic address: · Louisville Metabolic and Atherosclerosis Research Center (L-MARC), Louisville, Kentucky. · Sanofi, Bridgewater, New Jersey. · Regeneron, Tarrytown, New York. · Sanofi, Chilly-Mazarin, France. · Regeneron, Basking Ridge, New Jersey. · University of Iowa, Iowa City, Iowa. · Pubmed 27729106
2015
  • Section of Cardiovascular Research, Division of Atherosclerosis, Department of Medicine, Baylor College of Medicine, Houston, Texas; Center for Cardiovascular Research, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. Electronic address: · Orange County Research Center, Tustin, California. · Clinical Sciences, Global Innovative Pharma Business, Pfizer Inc., Groton, Connecticut. · Statistics, Global Innovative Pharma Business, Pfizer Inc., Groton, Connecticut. · Clinical Pharmacology, Global Innovative Pharma Business, Pfizer Inc., New York, New York. · Clinical Pharmacology, Global Innovative Pharma Business, Pfizer Inc., Groton, Connecticut. · Clinical Sciences, Global Innovative Pharma Business, Pfizer Inc., New York, New York. · Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky. · Pubmed 25784512
  • Louisville Metabolic and Atherosclerosis Research Center, 3288 Illinois Avenue, Louisville, KY, 40213, USA. · Pubmed 25431239
2014
  • Jacksonville Center for Clinical Research, Jacksonville, Florida. Electronic address: · Center for Clinical and Basic Research, Ballerup, Denmark. · Bethesda Health Research Center, Bethesda, Maryland. · Orange County Research Center, Tustin, California. · Amgen Inc., Thousand Oaks, California. · L-MARC Research Center, Louisville, Kentucky. · Pubmed 24691094
2013
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky. Electronic address: · Pubmed 24063830
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA. · Pubmed 22948945
2011
  • Louisville Metabolic and Atherosclerosis Research Center, Inc., Louisville, Kentucky 40213, USA. · Pubmed 21856592
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky, USA. · Pubmed 21596364
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY 40213, USA. · Pubmed 20837371
2010
  • Louisville Metabolic and Atherosclerosis Research Center, 3288 Illinois Ave, Louisville, KY 40213, USA. · Pubmed 20118387
2008
  • Louisville Metabolic and Atherosclerosis Research Center, 3288 Illinois Avenue, Louisville, KY 40213, USA. · Pubmed 18402536
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY 40213, USA. · Pubmed 18782465
2014
  • Comprehensive Health Insights Inc., a Humana Company, 325 W. Main St., WFP6W, 40202, Louisville, KY, USA, · Pubmed 25091271
8 Other Locations Show
Yearly article counts 012233143051
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.